Latest Leverage News

Aquirian Limited reports a robust first half of FY26 with revenue up 27.4% and EBITDA more than doubling, driven by strategic facility upgrades and promising joint ventures.

Recce Pharmaceuticals has received a $5.3 million R&D tax rebate from the Australian Taxation Office, providing a significant cash injection to support its innovative synthetic anti-infective drug development programs.

Norfolk Metals has completed Phase #1 of its maiden drilling campaign at the Carmen Copper Project in Chile, confirming significant higher-grade copper sulphide mineralisation open at depth. The company also secured firm commitments for a $2.1 million placement to fund ongoing exploration.

Little Green Pharma Ltd has agreed to acquire Cannatrek Ltd in a transformational merger that will create a leading vertically integrated medicinal cannabis group across Australia and Europe. The deal combines cultivation, manufacturing, distribution, clinics, and digital health platforms under one roof, positioning the combined entity for accelerated growth.

HighCom Limited appoints seasoned executive Geoffrey Knox as Executive Chairman and CEO, signaling a strategic push to strengthen its defence manufacturing and sustainment operations in Australia and the US.

Power Minerals has terminated its joint venture with Navigate Energy on the Rincon Lithium Project, opting to retain full ownership and seek new partners amid a buoyant lithium market.

Prospect Resources has confirmed significant gold by-product mineralisation at its Nyungu Central deposit, potentially boosting the economics of the Mumbezhi Copper Project in Zambia. Updated resource estimates incorporating these findings are expected in Q1 2026.

Racura Oncology has launched a strategic collaboration with Emory University to investigate (E,E)-bisantrene’s potential to overcome resistance to osimertinib in EGFR-mutated non-small cell lung cancer. This partnership aims to bolster Racura’s HARNESS-1 clinical trial and strengthen its position in the competitive lung cancer treatment landscape.

Robex Resources has received final court approval for its merger with Predictive Discovery, setting the stage for completion in early 2026 pending regulatory consents. This move could reshape the future of Robex’s West African gold projects.

Ion Video Limited has completed significant restructuring, strengthened its Melbourne-based tech team, and raised $2.95 million, positioning itself for a technology relaunch in February 2026 with a cash runway extending to mid-2027.

Kinatico Limited has reported a robust 42% increase in its SaaS revenue for Q2FY26, driven by strong operational execution and the launch of its new Kinatico Compliance solution.

Proteomics International Laboratories has appointed David Morris as CEO and Managing Director, marking a strategic shift towards commercialising its Promarker® diagnostic technology. Morris brings extensive global healthcare leadership experience to lead the company’s next growth phase.